UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________to _______________ Commission file number 001-41765 MIRA Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter) Florida 85-3 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 MIRA Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter) Florida 85-3354547 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131 (Address of principal executive offic ...

As filed with the Securities and Exchange Commission on December 18, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Registration No. 333- FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MIRA PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Florida 2834 85-3354547 (I.R.S. Employer Identification No.) 855 N Wolfe Stre ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Florida 85-3354547 (State or other jurisdiction of incorporation or organization) 855 N Wolfe Street, Suite 601 Baltimore, Maryland 21205 (Address of principal executive offices) (Zip Code ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________to _______________ Commission file number 001-41765 MIRA Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter) Florida 85-33 ...

AMENDMENT NO. 5 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MIRA PHARMACEUTICALS, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 As filed with the Securities and Exchange Commission on July 28, 2023 Registration No. 333-273024 (Exact name of registrant as specified in its charter) Florida (State or other jurisdiction of incorporation or organization) 85-3354547 (I.R.S. Employer Identification No.) 855 N Wolfe Street, Suite 601 Baltimore, Maryland 21205 ( ...

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MIRA PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Florida (State or other jurisdiction of incorporation or organization) As filed with the Securities and Exchange Commission on July 25, 2023 Registration No. 333-273024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 4 TO FORM S-1 2834 (Primary Standard Industrial Classification Code Number) 85-3354547 (I.R.S. Employer Identification ...

As filed with the Securities and Exchange Commission on July 21, 2023 Registration No. 333-273024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 3 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MIRA PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Florida (State or other jurisdiction of incorporation or organization) 2834 (Primary Standard Industrial Classification Code Number) 85-3354547 (I.R.S. Employer Identification ...

As filed with the Securities and Exchange Commission on July 18, 2023 Registration No. 333-273024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MIRA PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) 85-3354547 (I.R.S. Employer Identification No.) (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) Florida (S ...

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 As filed with the Securities and Exchange Commission on July 14, 2023 Registration No. 333-273024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 MIRA PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Florida (State or other jurisdiction of incorporation or organization) 2834 (Primary Standard Industrial Classification Code Number) 85-3354547 (I.R.S. Employer Identification ...